Chemoinformaics analysis of 17-Octadecynoic acid
| Molecular Weight | 280.452 | nRot | 15 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 2 |
| Exact Molecular Weight | 280.24 | nRing | 0 |
| Solubility: LogS | -5.065 | nHRing | 0 |
| Solubility: LogP | 6.375 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 53.0014 |
| nHD | 1 | BPOL | 32.9706 |
| QED | 0.315 |
| Synth | 2.101 |
| Natural Product Likeliness | 0.354 |
| NR-PPAR-gamma | 0.981 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0 |
| HIA | 0.014 |
| CACO-2 | -5.042 |
| MDCK | 0.0000199 |
| BBB | 0.084 |
| PPB | 0.976368 |
| VDSS | 0.771 |
| FU | 0.00666705 |
| CYP1A2-inh | 0.376 |
| CYP1A2-sub | 0.19 |
| CYP2c19-inh | 0.353 |
| CYP2c19-sub | 0.27 |
| CYP2c9-inh | 0.275 |
| CYP2c9-sub | 0.989 |
| CYP2d6-inh | 0.034 |
| CYP2d6-sub | 0.048 |
| CYP3a4-inh | 0.085 |
| CYP3a4-sub | 0.017 |
| CL | 1.814 |
| T12 | 0.588 |
| hERG | 0.05 |
| Ames | 0.009 |
| ROA | 0.04 |
| SkinSen | 0.934 |
| Carcinogencity | 0.188 |
| EI | 0.978 |
| Respiratory | 0.941 |
| NR-Aromatase | 0.089 |
| Antiviral | Yes |
| Prediction | 0.570081 |